Patent · US Active

Immunomodulatory antibodies

US11001638B2 · kind B2 · utility

1Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 4, 2016
Grant dateMay 11, 2021
Priority date—
Expiry dateNov 4, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/75
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to antibodies specific for 4-1BB and OX40, as well as to methods for using such antibodies and therapeutic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.